FibroBiologics’ (FBLG) “Buy” Rating Reiterated at D. Boral Capital
D. Boral Capital reissued their buy rating on shares of FibroBiologics (NASDAQ:FBLG – Free Report) in a research note issued to investors on Tuesday,Benzinga reports. The brokerage currently has a $16.00 price target on the stock. Other equities research analysts also recently issued research reports about the stock. Rodman & Renshaw began coverage on shares […]
D. Boral Capital reissued their buy rating on shares of FibroBiologics (NASDAQ:FBLG – Free Report) in a research note issued to investors on Tuesday,Benzinga reports. The brokerage currently has a $16.00 price target on the stock. Other equities research analysts also recently issued research reports about the stock. Rodman & Renshaw began coverage on shares […]
